Reuters

Four Democratic Led Us States Urge Fda Remove Abortion Pill Restrictions 2025 06 05

The Hill

5334969 Blue States Fda Abortion Pill Access

Four states petition the FDA to lift abortion pill restrictions

MS Now

Trump-appointed FDA chief to launch unnecessary review of abortion pill

Gizmodo

Four Democrat-Led States Ask FDA to Lift Restrictions on Abortion Pill

The rights new playbook to restrict access to abortion pills

Catholic News Agency

Government will conduct abortion pill review amid studies showing possible dangers

KristanHawkins

Joe Biden

Kamala Harris

Hakeem Jeffries

Kristyn Brandi

Xavier Becerra

Karine Jean-Pierre

Abigail Aiken

Angela Vasquez-Giroux

Ushma Upadhyay

William Tong

Kelly Baden

Stephen Vladeck

Adam Unikowsky

Ingrid Skop

Kristen Waggoner

Rachel O'Leary Carmona

Nancy Northup

Lisa Matsubara

Jessica West

Rebecca Gomperts

Ron Wyden

Will Mifepristone Be Banned in the US?

<span>The petition challenges FDA requirements under the Risk Evaluation and Mitigation Strategy program that mandate prescriber certification, patient agreement forms stating intent to end pregnancy, and pharmacy recordkeeping for mifepristone distribution.</span

National Review

The petition challenges FDA requirements under the Risk Evaluation and Mitigation Strategy program that mandate prescriber certification, patient agreement forms stating intent to end pregnancy, and pharmacy recordkeeping for mifepristone distribution.

<span>FDA Commissioner Marty Makary committed to conducting a safety review of mifepristone after Health and Human Services Secretary Robert F. Kennedy Jr. ordered the review, citing "alarming" data from a conservative think tank study.</span

Fierce Pharma

FDA Commissioner Marty Makary committed to conducting a safety review of mifepristone after Health and Human Services Secretary Robert F. Kennedy Jr. ordered the review, citing "alarming" data from a conservative think tank study.

<span>The Ethics and Public Policy Center report claimed nearly 11 percent of women experience serious adverse effects within 45 days of taking mifepristone, a rate 22 times higher than FDA data indicates, though the study lacks peer review.</span

The Washington Post

The Ethics and Public Policy Center report claimed nearly 11 percent of women experience serious adverse effects within 45 days of taking mifepristone, a rate 22 times higher than FDA data indicates, though the study lacks peer review.

<span>Medication abortions using mifepristone and misoprostol account for 63 percent of all U.S. abortions in 2023, with more than 100 scientific studies confirming the drug's safety over its 25-year history.</span

Medication abortions using mifepristone and misoprostol account for 63 percent of all U.S. abortions in 2023, with more than 100 scientific studies confirming the drug's safety over its 25-year history.

<span>The petition argues current restrictions discourage primary care providers from prescribing mifepristone, particularly affecting rural and underserved communities where abortion access requires lengthy travel to specialized clinics.</span

The petition argues current restrictions discourage primary care providers from prescribing mifepristone, particularly affecting rural and underserved communities where abortion access requires lengthy travel to specialized clinics.

Reuters #

The Hill #

NBC #5399

MS Now #

Gizmodo #

Vox #

Catholic News Agency #

<h2></h2>

Abortion

Four Democratic-led US states urge FDA to remove abortion pill restrictions

Pharmaceuticals

United States of America

The FDA must thoroughly review alarming new data showing mifepristone complications may be 22 times higher than previously reported. Insurance claims from over 865,000 prescriptions reveal nearly 11% of women experience potentially life-threatening complications within 45 days. Current safety restrictions exist for good reason and protect women from a drug that poses serious risks.

<span>The FDA must thoroughly review alarming new data showing mifepristone complications may be 22 times higher than previously reported. Insurance claims from over 865,000 prescriptions reveal nearly 11% of women experience potentially life-threatening complications within 45 days. Current safety restrictions exist for good reason and protect women from a drug that poses serious risks.</span>

The Washington Examiner

California joins Democratic-led states in petitioning FDA to lift abortion regulations on mifepristone

Four States Petition FDA to Lift Abortion Pill Restrictions

Four Democratic-ledStates USPetition states urge FDA to removeLift abortionAbortion pillPill restrictionsRestrictions

The Spin

The Controversies

Go Deeper